Click to view our statement on Accessibility

Suggested Searches

    Popular Searches

    Back
    Foley Viewpoints

    Ameron — A Big Leap Away From Foster-Gardner

    January 18, 2011

    Author(s)

    Eileen R. Ridley

    San Francisco 415.438.6469

    Related Insights

    View All Posts
    June 3, 2025 Foley Corporate Governance Update

    Texas Senate Bill 2337: Protecting Texas Companies and Their Directors, Shareholders and Boards from Proxy Advice Not in the Financial Interests of Shareholders

    On June 2, 2025, the Texas Legislature passed Senate Bill 2337, meaningfully regulating proxy advisors like ISS and Glass Lewis when providing proxy voting recommendations concerning Texas companies.
    September 25, 2025 Events

    Unclaimed Property Roundtable with Delaware State Escheator and Leading Practitioners  
    June 3, 2025 Health Care Law Today

    GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health

    Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.